Richard Mularski to Pulmonary Emphysema
This is a "connection" page, showing publications Richard Mularski has written about Pulmonary Emphysema.
Connection Strength
0.795
-
Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE. Ann Am Thorac Soc. 2024 Feb; 21(2):251-260.
Score: 0.234
-
Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2019 12 01; 200(11):1354-1362.
Score: 0.175
-
A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015 Sep; 46(3):651-62.
Score: 0.127
-
The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol. 2014 Oct; 21(4):288-97.
Score: 0.123
-
Endobronchial valve treatment for prolonged air leaks of the lung: a case series. Ann Thorac Surg. 2011 Jan; 91(1):270-3.
Score: 0.095
-
Nonsurgical causes of pneumoperitoneum. West J Med. 1999 Jan; 170(1):41-6.
Score: 0.041